Child With Adhd Asthma Dyslexia And Stuttering

Featured Article

This is a Phase 4 clinical trial to determine the effectiveness of using atomoxetine in children age 10 to 16 who have ADHD as well as dyslexia. The study will assess the effect of atomoxetine on basic reading skills,working memory, social, emotional, cognitive, educational, and affiliative functioning. This study is currently recruiting patients.

Read more

More information on "Child With Adhd Asthma Dyslexia And Stuttering"

From Our Experts

See more SharePosts »

From Our Sources

More on ADHD »